Skip to content

PSYC

Clarify Pharma PLC

Access


ISIN

GB00BMCD8M81

Bid

0.80

Mid

0.81

Ask

0.82

Key Information

Price Change
0.00%
Year High
1.25
Year Low
0.81
Last Trade
24 Mar 23
Market Cap
2.407M
Par
0.00
Bid
0.80
Mid Price
0.81
Ask
0.82
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
297.2M
Sector
Healthcare

About Clarify Pharma PLC

Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businesses that advance medicines based on psychedelic substances through rigorous science and clinical trials.

Clarify Pharma PLCAccess

Latest Trades

DateVolumePriceValue

17 Mar 23

08:42

50,0000.840,000

10 Mar 23

12:14

2,500,0000.822,050,000

10 Mar 23

12:14

2,500,0000.822,050,000

07 Dec 22

14:14

5,000,0000.482,400,000

09 Nov 22

11:59

150,0000.7105,000
View all trades

Latest Announcements

DateTitle

24 Nov 22

07:00

Clarify Pharma PLC - Acquisition of Shares

31 Aug 22

06:00

Clarify Pharma PLC - Interim results

30 May 22

15:27

Clarify Pharma PLC - Result of Annual General Meeting

05 May 22

06:00

Clarify Pharma PLC - Notice of AGM

05 May 22

06:00

Clarify Pharma PLC - Full Year Results
View all announcements

Address

Registered Address

9th Floor, 16 Great Queen Street, London, WC2B 5DG, England

Email

nl@nlconsulting.co.uk

Phone

+44 207 183 7407

Contacts

Corporate Adviser

First Sentinel Corporate Finance, 72 Charlotte Street, London , W1T 4QQ, United Kingdom

Registrar

Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal